LDV Capital's Evan Nisselson and Ash Cleary cover topics ranging from spectroscopy and nanomaterials to enhance food and agricultural production, to renewable energy forecasting and grid management, and predictive digital twins for the supply chain.
Read MoreMeet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.
If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.
Read MoreWe believe that visual technologies will continue to be the crux of advancements in materials science, across nanomaterials and metamaterials, resulting in the transformation of various industrial, medical and consumer applications. Embedded AI will enable materials to reconfigure themselves autonomously in response to their environment. As sensing abilities and algorithms improve, the full potential of navigating the compositional and configurational possibilities of materials will catalyze widespread transformation for optics, biomarker diagnostics, robotics, 3D printing and more.
Read MoreOn March 21, at our 10th Annual LDV Vision Summit, Evan Nisselson, Founder and General Partner at LDV Capital, will speak with Dr. Molly Gibson – Co-Founder and Chief Strategy and Innovation Officer at Generate:Biomedicines. They will discuss how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials, and more. This will have a tremendous impact on business and society.
In the lead-up to the Summit, Evan had the privilege of asking Dr. Gibson a few questions.
Read More
